Medical nutrition therapy and vitamin D supplementation improved nutritional status and quality of life in relapse systemic lupus erythematosus patient A case report

Main Article Content

Ayu Diandra Sari
Yohannessa Wulandari
Diyah Eka Andayani


Medical nutrition therapy (MNT) plays pivotal role in comprehensive management of autoimmune disease, includes systemic lupus erythematosus (SLE). Meanwhile, MNT for SLE is still not a concern in many international clinical practice guidelines. Many studies reported about nutritional declines and metabolic complications related to long term corticosteroid use in SLE patients, i.e. malnutrition, sarcopenia, hypovitaminosis D, hypertension and etc. Besides, obesity is more expected become important risk factor in SLE.


Download data is not yet available.

Article Details

Author Biographies

Yohannessa Wulandari, University of Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia

Department of Nutrition

Diyah Eka Andayani, University of Indonesia, Dr Cipto Mangunkusumo General Hospital, Jakarta, Indonesia

Department of Nutrition


Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term Systemic Corticosteroid Exposure: A Systematic Literature Review. Clin Ther 2017;39:2216–29.

Yasir M, Sonthalia S. Corticosteroid Adverse Effects [Internet]. StatPearls. StatPearls Publishing; 2019 [cited 2021 Jun 24]. Available from:

Attar SM, Siddiqui AM. Vitamin D defciency in patients with systemic lupus erythematosus. Oman Med J 2013;28:42–7.

Pangestu Y, Setiati S, Setiyohadi B, Sukmana N. Prevalence and factors associated with vitamin D deficiency in systemic lupus erythematosus patients. Indonesian Journal of Rheumatology 2013;4:4–84.

Hassanalilou T, Khalili L, Ghavamzadeh S, Shokri A, Payahoo L, Bishak YK. Role of vitamin D deficiency in systemic lupus erythematosus incidence and aggravation. Auto Immun Highlights 2018;9:1.

Muscle strength and quality of life improved after vitamin D supplementation among adult Saudi females. Clinical Nutrition Experimental 2019;26:34–43.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. Journal of Clinical Endocrinology and Metabolism 2012;97:1153–8.

Li M, Zhao Y, Zhang Z, Huang C, Liu Y, Gu J, et al. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus. Rheumatol Immunol Res 2020;1:5–23.

Da Hora TC, Lima K, Maciel RRBT. The effect of therapies on the quality of life of patients with systemic lupus erythematosus: A meta-analysis of randomized trials. Adv Rheumatol 2019;59:1–8.

Olesińska M, Saletra A. Quality of life in systemic lupus erythematosus and its measurement. Reumatologia 2018;56:45–54.

Pereira MG, Duarte S, Ferraz A, Santos M, Fontes L. Quality of life in patients with systemic lupus erythematosus: the mediator role of psychological morbidity and disease activity. Psychol Heal Med 2020;25:1247–57.

Hasan S, Ahmed S, Kiran R. Pemphigus vulgaris: an update on etiopathogenesis, clinical manifestations, diagnosis and treatment modalities. Int Res J Pharm 2019;10:1–6.

Macfarlane DP, Forbes S, Walker BR. Glucocorticoids and fatty acid metabolism in humans: Fuelling fat redistribution in the metabolic syndrome. J Endocrinol 2008;197:189–204.

Chotiyarnwong P, McCloskey E V. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nature Reviews Endocrinology. Nature Research 2020;16:437–47.

Hayat S, Magrey MN. Glucocorticoid-induced osteoporosis: Insights for the clinician. Cleveland Clinic Journal of Medicine 2020;87:417–26.

Gordon C. Long-term complications of systemic lupus erythematosus. Rheumatology 2002;41:1095–100.

Gregoriou S, Efthymiou O, Stefanaki C, Rigopoulos D. Management of pemphigus vulgaris: Challenges and solutions. Clinical, Cosmetic and Investigational Dermatology 2015;8:521–7.

Aras-López R, Xavier FE, Ferrer M, Balfagón G. Dexamethasone decreases neuronal nitric oxide release in mesenteric arteries from hypertensive rats through decreased protein kinase C activation. Clin Sci 2009;117:305–12.

Davidson ZE, Walker KZ, Truby H. Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies. Journal of Clinical Endocrinology and Metabolism 2012;97:738–44.

Skversky AL, Kumar J, Abramowitz MK, Kaskel FJ, Melamed ML. Association of glucocorticoid use and low 25-hydroxyvitamin D levels: Results from the National Health and Nutrition Examination Survey (NHANES): 2001-2006. J Clin Endocrinol Metab 2011;96:3838–45.

Anindito B, Hidayat R, Koesnoe S, Dewiasty E. Validity And Reliability Of Lupus Quality Of Life Questionnaire In Patients With Systemic Lupus Erythematosus In Indonesia. Indones J Rheumatol 2018;8:1–7.

Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: Not a passive bystander. Autoimmunity Reviews 2014;13:981–1000.

Procaccini C, Carbone F, Galgani M, La Rocca C, De Rosa V, Cassano S, et al. Obesity and susceptibility to autoimmune diseases. Expert Rev Clin Immunol 2011;7:287–94.

Arabi S, Molazadeh M, Rezaei N. Nutrition, Immunity, and Autoimmune Diseases. Nutr Immun 2019:415–36.

Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature 2017;542:177–85.

Islam MA, Khandker SS, Kotyla PJ, Hassan R. Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review. Front Immunol 2020;11:1477.

Klack K, Bonfa E, Neto EFB. Diet and nutritional aspects in systemic lupus erythematosus. Revista Brasileira de Reumatologia 2012;52:384–408.